317 related articles for article (PubMed ID: 26940275)
41. Array CGH in human leukemia: from somatics to genetics.
van der Veken LT; Buijs A
Cytogenet Genome Res; 2011; 135(3-4):260-70. PubMed ID: 21893961
[TBL] [Abstract][Full Text] [Related]
42. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.
Kim N; Choi S; Kim SM; Lee AC; Im K; Park HS; Kim JA; Kim K; Kim I; Chang YH; Lee DS
Leuk Lymphoma; 2019 Apr; 60(4):1053-1061. PubMed ID: 30714451
[TBL] [Abstract][Full Text] [Related]
43. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.
Tawana K; Brown AL; Churpek JE
Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019
[TBL] [Abstract][Full Text] [Related]
44. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
45. Genetic predisposition in acute leukaemia.
Wiggins M; Stevenson W
Int J Lab Hematol; 2020 Jun; 42 Suppl 1():75-81. PubMed ID: 32115888
[TBL] [Abstract][Full Text] [Related]
46. Inherited predisposition to acute myeloid leukemia.
Godley LA
Semin Hematol; 2014 Oct; 51(4):306-21. PubMed ID: 25311743
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic heterogeneity associated with germline
Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
[No Abstract] [Full Text] [Related]
48. Assessment of Factors Associated With the Evaluation of Children for Leukemia Predisposition Syndromes: A Retrospective Single-center Study.
D'Aquila KR; Kessler E; Cooper KL; Durst A; Meade J
J Pediatr Hematol Oncol; 2023 Jul; 45(5):e597-e602. PubMed ID: 37027191
[TBL] [Abstract][Full Text] [Related]
49. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
50. Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome.
Tomlinson CG; Sasa G; Aubert G; Martin-Giacalone B; Plon SE; Bryan TM; Bertuch AA; Gramatges MM
Leukemia; 2021 Jan; 35(1):269-273. PubMed ID: 32313107
[No Abstract] [Full Text] [Related]
51. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
52. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
53. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
54. Practical considerations for diagnosis and management of patients and carriers.
Niemeyer CM; Mecucci C
Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
[TBL] [Abstract][Full Text] [Related]
55. The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
Zhang L; McGraw KL; Sallman DA; List AF
Leuk Lymphoma; 2017 Aug; 58(8):1777-1790. PubMed ID: 27967292
[TBL] [Abstract][Full Text] [Related]
56. Transcription factor mutations as a cause of familial myeloid neoplasms.
Churpek JE; Bresnick EH
J Clin Invest; 2019 Feb; 129(2):476-488. PubMed ID: 30707109
[TBL] [Abstract][Full Text] [Related]
57. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
Wimmer K; Rosenbaum T; Messiaen L
Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
[TBL] [Abstract][Full Text] [Related]
58. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM;
Mod Pathol; 2024 Feb; 37(2):100397. PubMed ID: 38043791
[TBL] [Abstract][Full Text] [Related]
59. Germline Predisposition to Myelodysplastic Syndromes.
Gener-Ricos G; Gerstein YS; Hammond D; DiNardo CD
Cancer J; 2023 May-Jun 01; 29(3):143-151. PubMed ID: 37195770
[TBL] [Abstract][Full Text] [Related]
60. Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemia.
Heaney ML; Golde DW;
Curr Oncol Rep; 2000 Mar; 2(2):140-3. PubMed ID: 11122835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
